Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer
Clinical trial NCT05078151 · UNKNOWN
Trial details
- NCT number
- NCT05078151
- Sponsor
- Vall d'Hebron Institute of Oncology
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-01
- Primary completion
- 2022-09-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.